Northwestern Mutual Wealth Management’s INmune Bio INMB Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,300	Closed	-$29.1K	–	3571
2023 Q3	$29.1K	Hold	4,300	–	–	﹤0.01%	2181
2023 Q2	$39K	Hold	4,300	–	–	﹤0.01%	2079
2023 Q1	$27.8K	Hold	4,300	–	–	﹤0.01%	2151
2022 Q4	$27.3K	Hold	4,300	–	–	﹤0.01%	2130
2022 Q3	$27K	Hold	4,300	–	–	﹤0.01%	2099
2022 Q2	$38K	Buy	+4,300	New	+$32K	﹤0.01%	2008

Other funds holding INMB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

QCG

Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northwestern Mutual Wealth Management's INMB Position: Q4 2023 in Review

Northwestern Mutual Wealth Management sold out of INmune Bio (INMB) in Q4 2023, closing a stake of 4,300 shares — an estimated $29.1K sold.

Northwestern Mutual Wealth Management first reported a position in INMB in Q2 2022 and held it in 6 quarters. The position peaked at $39K in Q2 2023. 48 funds tracked by Wall St. Rank hold INMB as of Q4 2023.

Northwestern Mutual Wealth Management reported no remaining INmune Bio position as of Q4 2023 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 4,300 INmune Bio shares in Q4 2023, an estimated $29.1K.
Northwestern Mutual Wealth Management first reported a position in INmune Bio in Q2 2022 and held it in 6 quarters.
Northwestern Mutual Wealth Management's INmune Bio position peaked at $39K in Q2 2023.
48 funds tracked by Wall St. Rank held INmune Bio as of Q4 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2023, filed 13 Feb 2024.